Toshiki Yamada
Gifu-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: July 30, 2026
Enhancer of Zeste Homolog 1 and 2 Inhibitor-Induced Colitis Mimicking Immune Checkpoint Inhibitor-Induced Colitis.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.
Journal: Annals of hematology
Published: July 13, 2025
Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
Journal: Scientific reports
Published: February 10, 2023
Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma.
Journal: Leukemia & lymphoma
Published: December 30, 2021
Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.
Journal: International journal of hematology
Published: August 29, 2017
R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Journal: Hematological oncology
Published: August 03, 2017
Late Reactivation of Hepatitis B Virus after Chemotherapies for Hematological Malignancies: A Case Report and Review of the Literature.
Journal: Internal medicine (Tokyo, Japan)
Published: January 05, 2017
Symptomatic Acute Pancreatitis Induced by Nilotinib: A Report of Two Cases.
Journal: Internal medicine (Tokyo, Japan)
Published: December 02, 2016
Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions.
Journal: International journal of hematology
Published: January 04, 2016
A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy.
Journal: Hematological oncology
Published: July 10, 2015
CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Journal: Hematological oncology
Published: June 09, 2015
Last Updated: 09/26/2026